← Leaderboards
Joshua Epstein
University Of Arkansas Med Scis Ltl Rock
$6,765,629
Attributed
$6,765,629
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $952.4K · FY2005–13$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$6,765,629 · 6
By mechanism
P01$4,865,524 · 4
R01$1,900,105 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Arkansas Med Scis Ltl Rock
Same institution · by research overlap
- Bart Barlogie$10,937,441
- Teresita M Bellido$8,482,287
- Shmuel Yaccoby$3,520,012
- Robert L Jilka$4,255,374
- Randy S Haun$578,571
Others in their field
Top investigators on “Multiple Myeloma”
- David Heimbrook · Leidos Biomedical Research, Inc.$146,380,351
- Larry Arthur$41,717,333
- Charles A Coltman · Southwest Oncology Group$36,988,659
- Kenneth C Anderson · Dana-Farber Cancer Inst$25,497,347
- Irene M. Ghobrial · Dana-Farber Cancer Inst$22,402,686
- Nilsa Del Carmen Ramirez · Ohio State University$22,287,552
Research focus
Multiple MyelomaCellsBone MarrowFlow CytometryRecordsProgramsResearch PersonnelDesignOsteoclastsNeoplastic CellGrowthResearch InstituteArtsHistologyTherapeutic StudiesResourcesSpecimenMalignant NeoplasmsLeadIn VivoDisease RemissionPreventDiagnosisAffect
Grant awards (23)
Cell Analysis and Specimen Banking$458,587
P01 · FY2013 · CA · contact PI
Cell Analysis and Specimen Banking$467,821
P01 · FY2012 · CA · contact PI
Potentiating Natural Killer Cell Anti-Myeloma Effects$300,875
R01 · FY2010 · CA · contact PI
Osteoblasts and their mesenchymal progenitors in myeloma$244,741
R01 · FY2010 · CA · contact PI
Potentiating Natural Killer Cell Anti-Myeloma Effects$368,216
R01 · FY2009 · CA · contact PI
Cell Analysis and Specimen Banking$339,469
P01 · FY2009 · CA · contact PI
Osteoblasts and their mesenchymal progenitors in myeloma$244,741
R01 · FY2009 · CA · contact PI
Core--Cell Analysis and Sample Banking$631,443
P01 · FY2008 · CA · contact PI
Osteoblasts and their mesenchymal progenitors in myeloma$244,741
R01 · FY2008 · CA · contact PI
Core--Cell Analysis and Sample Banking$588,433
P01 · FY2007 · CA · contact PI
Osteoblasts and their mesenchymal progenitors in myeloma$244,741
R01 · FY2007 · CA · contact PI
Core--Cell Analysis and Sample Banking$437,367
P01 · FY2006 · CA · contact PI
Osteoblasts and their mesenchymal progenitors in myeloma$252,050
R01 · FY2006 · CA · contact PI
Core--Cell Analysis and Sample Banking$411,151
P01 · FY2005 · CA
Core--Cell Analysis and Sample Banking$413,057
P01 · FY2004 · CA
INTRINSIC AND INDUCED GROWTH CONTROL IN SCID HU MYELOMA MODEL$279,549
P01 · FY2002 · CA
CORE--CELL ANALYSIS$279,549
P01 · FY2002 · CA
CORE--CELL ANALYSIS$279,549
P01 · FY2001 · CA
INTRINSIC AND INDUCED GROWTH CONTROL IN SCID HU MYELOMA MODEL$279,549
P01 · FY2001 · CA
CORE--CELL ANALYSIS$0
P01 · FY2000 · CA
INTRINSIC AND INDUCED GROWTH CONTROL IN SCID HU MYELOMA MODEL$0
P01 · FY2000 · CA
INTRINSIC AND INDUCED GROWTH CONTROL IN SCID HU MYELOMA MODEL$0
P01 · FY2000 · CA
CORE--CELL ANALYSIS$0
P01 · FY2000 · CA